3.22.1 html 161 278 1 false 64 0 false 8 false false R1.htm 0001001 - Document - Cover Sheet http://www.pointbiopharma.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - Consolidated Balance Sheets Sheet http://www.pointbiopharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.pointbiopharma.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 1003004 - Statement - Consolidated Statements of Operations Sheet http://www.pointbiopharma.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1004005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.pointbiopharma.com/role/ConsolidatedStatementsofStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 1005006 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) Sheet http://www.pointbiopharma.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParentheticals Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) Statements 6 false false R7.htm 1006007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.pointbiopharma.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - Nature of business Sheet http://www.pointbiopharma.com/role/Natureofbusiness Nature of business Notes 8 false false R9.htm 2103102 - Disclosure - Summary of significant accounting policies Sheet http://www.pointbiopharma.com/role/Summaryofsignificantaccountingpolicies Summary of significant accounting policies Notes 9 false false R10.htm 2106103 - Disclosure - Business Combination Sheet http://www.pointbiopharma.com/role/BusinessCombination Business Combination Notes 10 false false R11.htm 2111104 - Disclosure - Cash and cash equivalents Sheet http://www.pointbiopharma.com/role/Cashandcashequivalents Cash and cash equivalents Notes 11 false false R12.htm 2113105 - Disclosure - Prepaid expenses and other current assets Sheet http://www.pointbiopharma.com/role/Prepaidexpensesandothercurrentassets Prepaid expenses and other current assets Notes 12 false false R13.htm 2116106 - Disclosure - Property, plant and equipment Sheet http://www.pointbiopharma.com/role/Propertyplantandequipment Property, plant and equipment Notes 13 false false R14.htm 2119107 - Disclosure - Accounts payable Sheet http://www.pointbiopharma.com/role/Accountspayable Accounts payable Notes 14 false false R15.htm 2122108 - Disclosure - Accrued expenses Sheet http://www.pointbiopharma.com/role/Accruedexpenses Accrued expenses Notes 15 false false R16.htm 2125109 - Disclosure - Mortgage payable Sheet http://www.pointbiopharma.com/role/Mortgagepayable Mortgage payable Notes 16 false false R17.htm 2127110 - Disclosure - Stockholders??? equity Sheet http://www.pointbiopharma.com/role/Stockholdersequity Stockholders??? equity Notes 17 false false R18.htm 2133111 - Disclosure - Share-based compensation Sheet http://www.pointbiopharma.com/role/Sharebasedcompensation Share-based compensation Notes 18 false false R19.htm 2139112 - Disclosure - Commitments and contingencies Sheet http://www.pointbiopharma.com/role/Commitmentsandcontingencies Commitments and contingencies Notes 19 false false R20.htm 2142113 - Disclosure - License agreements Sheet http://www.pointbiopharma.com/role/Licenseagreements License agreements Notes 20 false false R21.htm 2148114 - Disclosure - Income taxes Sheet http://www.pointbiopharma.com/role/Incometaxes Income taxes Notes 21 false false R22.htm 2155115 - Disclosure - Net loss per share Sheet http://www.pointbiopharma.com/role/Netlosspershare Net loss per share Notes 22 false false R23.htm 2159116 - Disclosure - Financial instruments risk management Sheet http://www.pointbiopharma.com/role/Financialinstrumentsriskmanagement Financial instruments risk management Notes 23 false false R24.htm 2161117 - Disclosure - Related party transactions Sheet http://www.pointbiopharma.com/role/Relatedpartytransactions Related party transactions Notes 24 false false R25.htm 2165118 - Disclosure - Employee benefit plan Sheet http://www.pointbiopharma.com/role/Employeebenefitplan Employee benefit plan Notes 25 false false R26.htm 2167119 - Disclosure - Subsequent events Sheet http://www.pointbiopharma.com/role/Subsequentevents Subsequent events Notes 26 false false R27.htm 2204201 - Disclosure - Summary of significant accounting policies (Policies) Sheet http://www.pointbiopharma.com/role/SummaryofsignificantaccountingpoliciesPolicies Summary of significant accounting policies (Policies) Policies 27 false false R28.htm 2307301 - Disclosure - Business Combination (Tables) Sheet http://www.pointbiopharma.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.pointbiopharma.com/role/BusinessCombination 28 false false R29.htm 2314302 - Disclosure - Prepaid expenses and other current assets (Tables) Sheet http://www.pointbiopharma.com/role/PrepaidexpensesandothercurrentassetsTables Prepaid expenses and other current assets (Tables) Tables http://www.pointbiopharma.com/role/Prepaidexpensesandothercurrentassets 29 false false R30.htm 2317303 - Disclosure - Property, plant and equipment (Tables) Sheet http://www.pointbiopharma.com/role/PropertyplantandequipmentTables Property, plant and equipment (Tables) Tables http://www.pointbiopharma.com/role/Propertyplantandequipment 30 false false R31.htm 2320304 - Disclosure - Accounts payable (Tables) Sheet http://www.pointbiopharma.com/role/AccountspayableTables Accounts payable (Tables) Tables http://www.pointbiopharma.com/role/Accountspayable 31 false false R32.htm 2323305 - Disclosure - Accrued expenses (Tables) Sheet http://www.pointbiopharma.com/role/AccruedexpensesTables Accrued expenses (Tables) Tables http://www.pointbiopharma.com/role/Accruedexpenses 32 false false R33.htm 2328306 - Disclosure - Stockholders??? equity (Tables) Sheet http://www.pointbiopharma.com/role/StockholdersequityTables Stockholders??? equity (Tables) Tables http://www.pointbiopharma.com/role/Stockholdersequity 33 false false R34.htm 2334307 - Disclosure - Share-based compensation (Tables) Sheet http://www.pointbiopharma.com/role/SharebasedcompensationTables Share-based compensation (Tables) Tables http://www.pointbiopharma.com/role/Sharebasedcompensation 34 false false R35.htm 2349308 - Disclosure - Income taxes (Tables) Sheet http://www.pointbiopharma.com/role/IncometaxesTables Income taxes (Tables) Tables http://www.pointbiopharma.com/role/Incometaxes 35 false false R36.htm 2356309 - Disclosure - Net loss per share (Tables) Sheet http://www.pointbiopharma.com/role/NetlosspershareTables Net loss per share (Tables) Tables http://www.pointbiopharma.com/role/Netlosspershare 36 false false R37.htm 2362310 - Disclosure - Related party transaction (Tables) Sheet http://www.pointbiopharma.com/role/RelatedpartytransactionTables Related party transaction (Tables) Tables http://www.pointbiopharma.com/role/Relatedpartytransactions 37 false false R38.htm 2402401 - Disclosure - Nature of business - Narrative (Details) Sheet http://www.pointbiopharma.com/role/NatureofbusinessNarrativeDetails Nature of business - Narrative (Details) Details 38 false false R39.htm 2405402 - Disclosure - Summary of significant accounting policies (Details) Sheet http://www.pointbiopharma.com/role/SummaryofsignificantaccountingpoliciesDetails Summary of significant accounting policies (Details) Details http://www.pointbiopharma.com/role/SummaryofsignificantaccountingpoliciesPolicies 39 false false R40.htm 2408403 - Disclosure - Business Combination (Details) Sheet http://www.pointbiopharma.com/role/BusinessCombinationDetails Business Combination (Details) Details http://www.pointbiopharma.com/role/BusinessCombinationTables 40 false false R41.htm 2409404 - Disclosure - Business Combination - Summary of Net proceeds (Details) Sheet http://www.pointbiopharma.com/role/BusinessCombinationSummaryofNetproceedsDetails Business Combination - Summary of Net proceeds (Details) Details 41 false false R42.htm 2410405 - Disclosure - Business Combination - Summary of Shares of Common Stock Issued (Details) Sheet http://www.pointbiopharma.com/role/BusinessCombinationSummaryofSharesofCommonStockIssuedDetails Business Combination - Summary of Shares of Common Stock Issued (Details) Details 42 false false R43.htm 2412406 - Disclosure - Cash and cash equivalents (Details) Sheet http://www.pointbiopharma.com/role/CashandcashequivalentsDetails Cash and cash equivalents (Details) Details http://www.pointbiopharma.com/role/Cashandcashequivalents 43 false false R44.htm 2415407 - Disclosure - Prepaid expenses and other current assets (Details) Sheet http://www.pointbiopharma.com/role/PrepaidexpensesandothercurrentassetsDetails Prepaid expenses and other current assets (Details) Details http://www.pointbiopharma.com/role/PrepaidexpensesandothercurrentassetsTables 44 false false R45.htm 2418408 - Disclosure - Property, plant and equipment (Details) Sheet http://www.pointbiopharma.com/role/PropertyplantandequipmentDetails Property, plant and equipment (Details) Details http://www.pointbiopharma.com/role/PropertyplantandequipmentTables 45 false false R46.htm 2421409 - Disclosure - Accounts payable (Details) Sheet http://www.pointbiopharma.com/role/AccountspayableDetails Accounts payable (Details) Details http://www.pointbiopharma.com/role/AccountspayableTables 46 false false R47.htm 2424410 - Disclosure - Accrued expenses (Details) Sheet http://www.pointbiopharma.com/role/AccruedexpensesDetails Accrued expenses (Details) Details http://www.pointbiopharma.com/role/AccruedexpensesTables 47 false false R48.htm 2426411 - Disclosure - Mortgage payable (Details) Sheet http://www.pointbiopharma.com/role/MortgagepayableDetails Mortgage payable (Details) Details http://www.pointbiopharma.com/role/Mortgagepayable 48 false false R49.htm 2429412 - Disclosure - Stockholders??? equity (Details) Sheet http://www.pointbiopharma.com/role/StockholdersequityDetails Stockholders??? equity (Details) Details http://www.pointbiopharma.com/role/StockholdersequityTables 49 false false R50.htm 2430413 - Disclosure - Stockholders??? equity - Warrants (Details) Sheet http://www.pointbiopharma.com/role/StockholdersequityWarrantsDetails Stockholders??? equity - Warrants (Details) Details 50 false false R51.htm 2431414 - Disclosure - Stockholders??? equity - Pricing model (Details) Sheet http://www.pointbiopharma.com/role/StockholdersequityPricingmodelDetails Stockholders??? equity - Pricing model (Details) Details 51 false false R52.htm 2432415 - Disclosure - Stockholders??? equity - Warrants exercised (Details) Sheet http://www.pointbiopharma.com/role/StockholdersequityWarrantsexercisedDetails Stockholders??? equity - Warrants exercised (Details) Details 52 false false R53.htm 2435416 - Disclosure - Share-based compensation - Narrative (Details) Sheet http://www.pointbiopharma.com/role/SharebasedcompensationNarrativeDetails Share-based compensation - Narrative (Details) Details 53 false false R54.htm 2436417 - Disclosure - Share-based compensation - Share-based compensation expense (Details) Sheet http://www.pointbiopharma.com/role/SharebasedcompensationSharebasedcompensationexpenseDetails Share-based compensation - Share-based compensation expense (Details) Details 54 false false R55.htm 2437418 - Disclosure - Share-based compensation - Assumptions used in Black-Scholes-Merton option-pricing model (Details) Sheet http://www.pointbiopharma.com/role/SharebasedcompensationAssumptionsusedinBlackScholesMertonoptionpricingmodelDetails Share-based compensation - Assumptions used in Black-Scholes-Merton option-pricing model (Details) Details 55 false false R56.htm 2438419 - Disclosure - Share-based compensation - Summarizes activity relating to options to purchase stock (Details) Sheet http://www.pointbiopharma.com/role/SharebasedcompensationSummarizesactivityrelatingtooptionstopurchasestockDetails Share-based compensation - Summarizes activity relating to options to purchase stock (Details) Details 56 false false R57.htm 2440420 - Disclosure - Commitments and contingencies - Property in development commitment (Details) Sheet http://www.pointbiopharma.com/role/CommitmentsandcontingenciesPropertyindevelopmentcommitmentDetails Commitments and contingencies - Property in development commitment (Details) Details 57 false false R58.htm 2441421 - Disclosure - Commitments and contingencies - Clinical trial and commercial commitments & License agreements (Details) Sheet http://www.pointbiopharma.com/role/CommitmentsandcontingenciesClinicaltrialandcommercialcommitmentsLicenseagreementsDetails Commitments and contingencies - Clinical trial and commercial commitments & License agreements (Details) Details 58 false false R59.htm 2443422 - Disclosure - License agreements - License agreement with Scintomics GMBH (Details) Sheet http://www.pointbiopharma.com/role/LicenseagreementsLicenseagreementwithScintomicsGMBHDetails License agreements - License agreement with Scintomics GMBH (Details) Details 59 false false R60.htm 2444423 - Disclosure - License agreements - Research and license agreements with Bach Sciences LLC (Details) Sheet http://www.pointbiopharma.com/role/LicenseagreementsResearchandlicenseagreementswithBachSciencesLLCDetails License agreements - Research and license agreements with Bach Sciences LLC (Details) Details 60 false false R61.htm 2445424 - Disclosure - License agreements - License agreement with Avacta Lifesciences Limited (Details) Sheet http://www.pointbiopharma.com/role/LicenseagreementsLicenseagreementwithAvactaLifesciencesLimitedDetails License agreements - License agreement with Avacta Lifesciences Limited (Details) Details 61 false false R62.htm 2446425 - Disclosure - License agreements - License agreement with Canadian Molecular Probe Consortium (Details) Sheet http://www.pointbiopharma.com/role/LicenseagreementsLicenseagreementwithCanadianMolecularProbeConsortiumDetails License agreements - License agreement with Canadian Molecular Probe Consortium (Details) Details 62 false false R63.htm 2447426 - Disclosure - License agreements - License agreement with Belgian Nuclear Research Centre (Details) Sheet http://www.pointbiopharma.com/role/LicenseagreementsLicenseagreementwithBelgianNuclearResearchCentreDetails License agreements - License agreement with Belgian Nuclear Research Centre (Details) Details 63 false false R64.htm 2450427 - Disclosure - Income taxes - Loss before provision for income taxes (Details) Sheet http://www.pointbiopharma.com/role/IncometaxesLossbeforeprovisionforincometaxesDetails Income taxes - Loss before provision for income taxes (Details) Details 64 false false R65.htm 2451428 - Disclosure - Income taxes - Provision for income taxes (Details) Sheet http://www.pointbiopharma.com/role/IncometaxesProvisionforincometaxesDetails Income taxes - Provision for income taxes (Details) Details 65 false false R66.htm 2452429 - Disclosure - Income taxes - Reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate (Details) Sheet http://www.pointbiopharma.com/role/IncometaxesReconciliationoftheUnitedStatesfederalstatutoryincometaxratetotheCompanyseffectiveincometaxrateDetails Income taxes - Reconciliation of the United States federal statutory income tax rate to the Company's effective income tax rate (Details) Details 66 false false R67.htm 2453430 - Disclosure - Income taxes - Net deferred tax assets (Details) Sheet http://www.pointbiopharma.com/role/IncometaxesNetdeferredtaxassetsDetails Income taxes - Net deferred tax assets (Details) Details 67 false false R68.htm 2454431 - Disclosure - Income taxes - Narrative (Details) Sheet http://www.pointbiopharma.com/role/IncometaxesNarrativeDetails Income taxes - Narrative (Details) Details 68 false false R69.htm 2457432 - Disclosure - Net loss per share - Summary of basic and diluted net loss per share (Details) Sheet http://www.pointbiopharma.com/role/NetlosspershareSummaryofbasicanddilutednetlosspershareDetails Net loss per share - Summary of basic and diluted net loss per share (Details) Details 69 false false R70.htm 2458433 - Disclosure - Net loss per share - Anti-dilutive effect (Details) Sheet http://www.pointbiopharma.com/role/NetlosspershareAntidilutiveeffectDetails Net loss per share - Anti-dilutive effect (Details) Details 70 false false R71.htm 2460434 - Disclosure - Financial instruments risk management (Details) Sheet http://www.pointbiopharma.com/role/FinancialinstrumentsriskmanagementDetails Financial instruments risk management (Details) Details http://www.pointbiopharma.com/role/Financialinstrumentsriskmanagement 71 false false R72.htm 2463435 - Disclosure - Related party transactions - Schedule of Related Party Transactions (Details) Sheet http://www.pointbiopharma.com/role/RelatedpartytransactionsScheduleofRelatedPartyTransactionsDetails Related party transactions - Schedule of Related Party Transactions (Details) Details 72 false false R73.htm 2464436 - Disclosure - Related party transactions -Narrative (Details) Sheet http://www.pointbiopharma.com/role/RelatedpartytransactionsNarrativeDetails Related party transactions -Narrative (Details) Details 73 false false R74.htm 2466437 - Disclosure - Employee benefit plan (Details) Sheet http://www.pointbiopharma.com/role/EmployeebenefitplanDetails Employee benefit plan (Details) Details http://www.pointbiopharma.com/role/Employeebenefitplan 74 false false R75.htm 2468438 - Disclosure - Subsequent events (Details) Sheet http://www.pointbiopharma.com/role/SubsequenteventsDetails Subsequent events (Details) Details http://www.pointbiopharma.com/role/Subsequentevents 75 false false All Reports Book All Reports pnt-20220325.htm exhibit231-sx1a.htm pnt-20220325.xsd pnt-20220325_cal.xml pnt-20220325_def.xml pnt-20220325_lab.xml pnt-20220325_pre.xml pnt-20220325_g1.jpg pnt-20220325_g2.jpg pnt-20220325_g3.jpg pnt-20220325_g4.jpg pnt-20220325_g5.jpg pnt-20220325_g6.jpg pnt-20220325_g7.jpg pnt-20220325_g8.jpg pnt-20220325_g9.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true